Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction.
Hadjihambi A., Konstantinou C., Klohs J., Monsorno K., Le Guennec A., Donnelly C., Cox I.J., Kusumbe A., Hosford P.S., Soffientini U. et al., 2023/01. Journal of hepatology, 78 (1) pp. 180-190. Peer-reviewed.
ici le détail